The IGF receptor as anticancer treatment target.
The type 1 insulin-like growth factor receptor (IGF-1R) is overexpressed by many tumours and mediates proliferation, motility and apoptosis protection. Tumour growth and metastasis can be blocked by agents that inhibit IGF-1R expression or function, suggesting the IGF-1R as a promising treatment tar...
| Main Author: | |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
2004
|